Pfizer (PFE)
(Delayed Data from NYSE)
$29.42 USD
-0.24 (-0.81%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $29.41 -0.01 (-0.03%) 6:36 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Pfizer Inc. [PFE]
Reports for Purchase
Showing records 101 - 120 ( 574 total )
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 4123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Biotechnology- Weekly Retail Sales Tracker for Solid Tumors - Week Ended March 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended March 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 32123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 31123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 3.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 3/3/23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 3123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended February 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 17.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 22123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 2/10/23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended February 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 10.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for PFE 21123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended February 3.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Weekly Neurology Prescription Sales Tracker - Week Ending 2/3/23
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Pfizer Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department